Teladoc CFO Mala Murthy to Resign in November

An update from Teladoc ( (TDOC) ) is now available.

Teladoc Health announced that its Chief Financial Officer, Mala Murthy, will resign effective November 21, 2025, to pursue an opportunity outside the healthcare industry. The company has begun searching for a new CFO and will implement an interim leadership structure to ensure a smooth transition. In addition, Teladoc reaffirmed its full-year 2025 financial outlook and provided preliminary third-quarter financial results, reporting $626.4 million in revenue and $69.9 million in adjusted EBITDA.

The most recent analyst rating on (TDOC) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Teladoc stock, see the TDOC Stock Forecast page.

Spark’s Take on TDOC Stock

According to Spark, TipRanks’ AI Analyst, TDOC is a Neutral.

Teladoc’s overall stock score reflects significant financial challenges, with persistent net losses and negative profitability metrics being the most impactful factors. While there are positive aspects such as a high gross profit margin and positive operating cash flows, the company’s inconsistent revenue growth and ongoing operational losses are concerning. Technical analysis shows mixed signals, and the valuation is unattractive due to a negative P/E ratio. The earnings call highlighted some strategic initiatives and improvements, but challenges in key segments remain significant hurdles.

To see Spark’s full report on TDOC stock, click here.

More about Teladoc

Teladoc Health is a global leader in virtual care, providing telehealth services that connect patients with healthcare professionals remotely. The company focuses on delivering comprehensive virtual healthcare solutions to enhance patient access and improve health outcomes.

Average Trading Volume: 7,000,233

Technical Sentiment Signal: Sell

Current Market Cap: $1.53B

For detailed information about TDOC stock, go to TipRanks’ Stock Analysis page.